Template:Diltiazem: Difference between revisions

Latest revision as of 22:20, 5 March 2014

Diltiazem
CARDIZEM tablet^® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings
Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
CARDIZEM LA tablet extended release^® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings
Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Labels and Packages
DILTIAZEM HYDROCHLORIDE injection^® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings
Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Diltiazem
ClinicalTrials.gov

@@ Line 38: / Line 38: @@
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Diltiazem hydrochloride tablet labels and packages|Labels and Packages]]
 |-
-! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left |CARDIZEM® tablet extended release<sup>®</sup> FDA Package Insert
+! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left |CARDIZEM LA tablet extended release<sup>®</sup> FDA Package Insert
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Diltiazem hydrochloride tablet extended release indications and usage|Indications and Usage]]